🕵️ SILO Pharma, Inc. ($SILO)
SEC insider & ownership activity, last 12 months · CIK 1514183 · every row links its SEC filing
Over the last 12 months insiders bought $8K with no open-market selling against it. Weisblum Eric bought $8K (Nov–Dec). One red-flag 8-K in the window: Delisting notice (3.01), Dec 24, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $8K (6 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Weisblum Eric | 6 | $8K | 0 | – | Dec 15, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Mitchell P. Kopin | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel B. Asher | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Advisorshares Trust | 6.7% | 13G | Jul 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 9, 2026 | filing ↗ |
| Other events (8.01) | Jul 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 20, 2026 | filing ↗ |
| Other events (8.01) | Feb 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 20, 2026 | filing ↗ |
| Delisting notice (3.01) | Dec 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 24, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 24, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Aug 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing ↗ |